PE20130316A1 - Combinacion de ibuprofeno y l-arginina - Google Patents
Combinacion de ibuprofeno y l-argininaInfo
- Publication number
- PE20130316A1 PE20130316A1 PE2012002113A PE2012002113A PE20130316A1 PE 20130316 A1 PE20130316 A1 PE 20130316A1 PE 2012002113 A PE2012002113 A PE 2012002113A PE 2012002113 A PE2012002113 A PE 2012002113A PE 20130316 A1 PE20130316 A1 PE 20130316A1
- Authority
- PE
- Peru
- Prior art keywords
- ibuprofen
- arginine
- combination
- tablet
- pharmaceutical combination
- Prior art date
Links
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001680 ibuprofen Drugs 0.000 title abstract 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 title abstract 2
- 239000003826 tablet Substances 0.000 abstract 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N Arginine Chemical compound OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 230000001760 anti-analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UNA COMBINACION FARMACEUTICA QUE COMPRENDE A) IBUPROFENO Y B) L-ARGININA, EN DONDE LA PROPORCION EN PESO DE IBUPROFENO/L-ARGININA ES 1.6 Y 5.6, CON EXCEPCION DEL VALOR 1.97. REFERIDO ADEMAS A UNA COMPOSICION QUE COMPRENDE LA COMBINACION FARMACEUTICA, LA CUAL SE ENCUENTRA EN FORMA DE CAPSULA, TABLETA, COMPRIMIDO, SUSPENSION, GRANULADO O POLVO. DICHA COMBINACION ES UTIL COMO ANTIPIRETICO, ANTIINFLAMATORIO Y/O ANALGESICO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2010004974A MX2010004974A (es) | 2010-05-04 | 2010-05-04 | Combinacion de un aine y un aminoacido. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20130316A1 true PE20130316A1 (es) | 2013-03-17 |
Family
ID=44903664
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2012002113A PE20130316A1 (es) | 2010-05-04 | 2011-04-28 | Combinacion de ibuprofeno y l-arginina |
| PE2016000218A PE20170136A1 (es) | 2010-05-04 | 2016-02-02 | Combinacion de un aine y un aminoacido |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2016000218A PE20170136A1 (es) | 2010-05-04 | 2016-02-02 | Combinacion de un aine y un aminoacido |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9186342B2 (es) |
| AR (1) | AR081007A1 (es) |
| BR (1) | BR112012028300A2 (es) |
| CA (1) | CA2798420C (es) |
| CL (1) | CL2012003065A1 (es) |
| CO (1) | CO6592037A2 (es) |
| CR (1) | CR20120554A (es) |
| DO (1) | DOP2012000280A (es) |
| EC (1) | ECSP13012765A (es) |
| ES (1) | ES2424417B1 (es) |
| GT (1) | GT201200295A (es) |
| MX (1) | MX2010004974A (es) |
| PE (2) | PE20130316A1 (es) |
| WO (1) | WO2011138653A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019010692A (es) * | 2019-09-06 | 2022-07-06 | Alparis Sa De Cv | Compuestos de curcumina y aminoácidos básicos. |
| US11969400B2 (en) * | 2021-03-23 | 2024-04-30 | Kumara V. Nibhanipudi | Ibuprofen for symptomatic treatment of diarrheas in HIV patients |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1209667B (it) | 1985-11-12 | 1989-08-30 | Zambon Spa | Composizione effeverscente adattivita' analgesica. |
| IT1197038B (it) * | 1986-08-01 | 1988-11-25 | Zambon Spa | Composizione farmaceutica ad attivita' analgesica |
| IT1264856B1 (it) * | 1993-06-21 | 1996-10-17 | Zambon Spa | Composizione farmaceutica ad attivita' analgesica |
| ES2253326T3 (es) | 2001-11-02 | 2006-06-01 | Cumberland Pharmaceuticals Inc. | Composicion farmaceutica de acido 2-(4-isobutilfenilo)propionico. |
| US6727286B2 (en) * | 2001-11-02 | 2004-04-27 | Cumberland Pharmaceuticals Inc. | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
| CN101889997B (zh) * | 2010-07-26 | 2012-10-03 | 石家庄中硕药业集团有限公司 | 一种注射用的含有布洛芬的药物组合物 |
-
2010
- 2010-05-04 MX MX2010004974A patent/MX2010004974A/es active IP Right Grant
-
2011
- 2011-04-28 WO PCT/IB2011/000916 patent/WO2011138653A1/es active Application Filing
- 2011-04-28 ES ES201290078A patent/ES2424417B1/es not_active Expired - Fee Related
- 2011-04-28 CA CA2798420A patent/CA2798420C/en not_active Expired - Fee Related
- 2011-04-28 BR BR112012028300A patent/BR112012028300A2/pt not_active Application Discontinuation
- 2011-04-28 PE PE2012002113A patent/PE20130316A1/es active IP Right Grant
- 2011-04-28 US US13/696,022 patent/US9186342B2/en active Active
- 2011-05-04 AR ARP110101530A patent/AR081007A1/es unknown
-
2012
- 2012-10-30 CR CR20120554A patent/CR20120554A/es unknown
- 2012-10-31 DO DO2012000280A patent/DOP2012000280A/es unknown
- 2012-10-31 GT GT201200295A patent/GT201200295A/es unknown
- 2012-10-31 CL CL2012003065A patent/CL2012003065A1/es unknown
- 2012-11-23 CO CO12212627A patent/CO6592037A2/es not_active Application Discontinuation
-
2013
- 2013-07-15 EC ECSP13012765 patent/ECSP13012765A/es unknown
-
2016
- 2016-02-02 PE PE2016000218A patent/PE20170136A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GT201200295A (es) | 2014-01-03 |
| US9186342B2 (en) | 2015-11-17 |
| US20130109754A1 (en) | 2013-05-02 |
| CO6592037A2 (es) | 2013-01-02 |
| ECSP13012765A (es) | 2013-09-30 |
| BR112012028300A2 (pt) | 2016-11-01 |
| ES2424417B1 (es) | 2014-11-26 |
| AR081007A1 (es) | 2012-05-30 |
| WO2011138653A1 (es) | 2011-11-10 |
| DOP2012000280A (es) | 2012-12-31 |
| CR20120554A (es) | 2013-02-01 |
| CA2798420A1 (en) | 2011-11-10 |
| ES2424417R1 (es) | 2013-12-20 |
| RU2012151921A (ru) | 2014-06-10 |
| ES2424417A2 (es) | 2013-10-01 |
| PE20170136A1 (es) | 2017-03-05 |
| CL2012003065A1 (es) | 2013-01-11 |
| MX2010004974A (es) | 2011-11-23 |
| CA2798420C (en) | 2018-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015008627A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| MX2015008628A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| SG10201810985XA (en) | Tofacitinib oral sustained release dosage forms | |
| AR091465A1 (es) | Una composicion farmaceutica que contiene acido nicotinico y/o nicotinamida y/o triptofano para influenciar positivamente la microbiota intestinal | |
| EA201590161A1 (ru) | Составы этанерцепта, отличающиеся заметным уменьшением содержания частиц довидимого диапазона | |
| BR112015011430A2 (pt) | composição para liberação imediata e prolongada | |
| MX344846B (es) | Combinacion de granulos cargados activos con activos adicionales. | |
| EA201590617A1 (ru) | Композиции алкилированного циклодекстрина и способы их получения и применения | |
| MX2016003754A (es) | Una composicion farmaceutica estable que contiene amlodipina y valsartan. | |
| BR112014020992A2 (pt) | Composto,uso de composto na fabricação de um medicamento e composição farmacêutica | |
| CL2016001094A1 (es) | Silicato de zirconio microporoso para el tratamiento de hipercalemia. | |
| MX363389B (es) | Composicion farmaceutica que comprende ivabradina amorfa. | |
| MX2016006087A (es) | Formulaciones de desintegracion rapida y metodos de uso. | |
| EA201590708A1 (ru) | Модифицированные производные гиалуроновой кислоты и их применение | |
| PE20130316A1 (es) | Combinacion de ibuprofeno y l-arginina | |
| UA119441C2 (uk) | Посилювачі водорозчинності на основі глікогену | |
| EA201500313A1 (ru) | Стабилизированная аморфная форма агомелатина, способ ее изготовления и фармацевтические композиции, ее содержащие | |
| PE20151432A1 (es) | Formulaciones de lorazepam de liberacion sostenida | |
| BR112017022855A2 (pt) | combinação de dose fixa inviolável que provê liberação rápida de dois fármacos a partir de partículas e um pó | |
| TR201005419A2 (tr) | Valsartan içeren farmasötik bileşim. | |
| TH119267B (th) | หน้าตัดโลหะ | |
| TH119263B (th) | หน้าตัดโลหะ | |
| TH119251B (th) | หน้าตัดโลหะ | |
| TH119255B (th) | หน้าตัดโลหะ | |
| TH119262B (th) | หน้าตัดโลหะ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |